Search by Drug Name or NDC

    NDC 66993-0821-30 pioglitazone and glimepiride 2; 30 mg/1; mg/1 Details

    pioglitazone and glimepiride 2; 30 mg/1; mg/1

    pioglitazone and glimepiride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Prasco Laboratories. The primary component is GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE.

    Product Information

    NDC 66993-0821
    Product ID 66993-821_d682ddb2-aeae-456a-b7ea-3e5c2e9b75bd
    Associated GPIs 27997802400320
    GCN Sequence Number 061389
    GCN Sequence Number Description pioglitazone HCl/glimepiride TABLET 30 MG-2 MG ORAL
    HIC3 C4R
    HIC3 Description ANTIHYPERGLYCEMIC, THIAZOLIDINEDIONE-SULFONYLUREA
    GCN 97181
    HICL Sequence Number 033991
    HICL Sequence Number Description PIOGLITAZONE HCL/GLIMEPIRIDE
    Brand/Generic Generic
    Proprietary Name pioglitazone and glimepiride
    Proprietary Name Suffix n/a
    Non-Proprietary Name pioglitazone and glimepiride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2; 30
    Active Ingredient Units mg/1; mg/1
    Substance Name GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
    Labeler Name Prasco Laboratories
    Pharmaceutical Class PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Sulfonylurea Compounds [CS], Sulfonylurea [EPC], Thiaz
    DEA Schedule n/a
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA021925
    Listing Certified Through 2024-12-31

    Package

    NDC 66993-0821-30 (66993082130)

    NDC Package Code 66993-821-30
    Billing NDC 66993082130
    Package 30 TABLET in 1 BOTTLE (66993-821-30)
    Marketing Start Date 2015-08-04
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL ea385b3d-cb4c-4550-97b0-93a86533f6dc Details

    Revised: 12/2021